Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kurt Prof Dr Klemm"'
Autor:
Michael Przybylski, Thomas Denzinger, Kurt Prof Dr Klemm, S. Haas, W Ise, Volker Gekeler, Volker Dr Figala, Wolf-Rüdiger Ulrich, C Borchers, Rainer Boer
Publikováno v:
Molecular Pharmacology. 61:1366-1376
Human P-glycoprotein (P-gp), an integral membrane transport protein, is responsible for the efflux of various drugs, including cytostatics from cancer cells leading to multidrug resistance. P-gp is composed of two homologous half domains, each carryi
Autor:
I. Utz, Kurt Prof Dr Klemm, C. Schachtele, Florian Überall, Volker Gekeler, Rainer Boer, Johann Hofmann, W Ise, C Schubert, H. Grunicke, K.H. Sanders
Publikováno v:
British Journal of Cancer
Inhibition of protein kinase C (PKC) is discussed as a new approach for overcoming multidrug resistance (MDR) in cancer chemotherapy. For evaluation of this concept we applied the bisindolylmaleimide GF 109203X, which shows a highly selective inhibit
Autor:
Ewald Hannappel, Klaus P. Schäfer, Tilman Voss, Kurt Prof Dr Klemm, Andrea Schäfer, Per F. Nielsen, Jörg Maaßen, Bernhard Landis, Michael Przybylski, Claudia S. Maier
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1138:261-267
The primary structures of human pulmonary surfactant-associated proteins SP-A, SP-B and SP-C isolated from lung lavage of patients with alveolar proteinosis exhibit significant differences from lung surfactant proteins isolated from lungs of healthy
Autor:
Michael Przybylski, J Conrad, C Borchers, W. R. Ulrich, Rainer Boer, Volker Gekeler, Kurt Prof Dr Klemm, W. Ise
Publikováno v:
Peptides 1994 ISBN: 9789072199218
Peptides 1994
Peptides 1994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0582e10c9a68c92178255c2a4cd9380
https://doi.org/10.1007/978-94-011-1468-4_369
https://doi.org/10.1007/978-94-011-1468-4_369
Autor:
Florian Überall, Kurt Prof Dr Klemm, H. Grunicke, W Ise, K.H. Sanders, Johann Hofmann, Volker Gekeler, C Schubert, Rainer Boer
Publikováno v:
Anti-Cancer Drugs. 5:28